Top 5 Takeaways Reemergence of Poliovirus in Malawi: Despite the WHO’s declaration in 2020 that the African Region was free from wild poliovirus, a case was confirmed in Malawi in

Top 5 Takeaways Novel OPV2 Shows Genetic Stability: Global genomic surveillance confirms the genetic stability of the novel oral poliovirus vaccine type 2 (nOPV2), maintaining the primary attenuating site’s integrity

Top 5 Takeaways Global Surveillance Enhancements: In 2022–2023, 71.4% of 28 priority countries met national acute flaccid paralysis (AFP) surveillance indicator targets, and environmental surveillance sites increased, supporting the global

Top 5 Takeaways Confirmed Case of Poliomyelitis in Unvaccinated Adult: In June 2022, an unvaccinated adult in New York developed paralytic poliomyelitis, marking a rare occurrence in the U.S., where

Top 5 Takeaways A rare case of type 3 Vaccine-Derived Poliovirus (VDPV3) was detected in an infant with a primary immunodeficiency disorder (PID) in Chongqing, China. Surveillance for poliovirus in

Top 5 Takeaways Wastewater Testing Identified PV2 in New York: Wastewater testing in New York detected poliovirus type 2 (PV2), genetically related to the virus from a paralytic polio case

Top 5 Takeaways Reduction in Polio Cases: Afghanistan reported only two cases of wild poliovirus type 1 (WPV1) in 2022 up to September, a reduction from previous years, with no